International Journal of Oncology · 2007 · 39 citations · 22 references
MedicineOncologyOral BiologyMolecular OncologyNeoplasiaOral OncologyMalignant Oral TumorsOral CarcinogenesisOral Cavity CancerOral NeoplasiaSquamous Cell CarcinomaCell Growth RegulationInsulin-like Growth Factor-1Insulin-like Growth FactorsMitogenic Signaling PathwaysOncogenic Mitogenic SignalingOral Epithelial CarcinogenesisOral Epithelial Cell BiologyOral Mucosal Epithelium
The insulin-like growth factors (IGFs) are a family of mitogenic proteins involved in the regulation of cell growth and differentiation. The presence and role of the IGF system in oral mucosal epithelium is not clear but could influence our understanding of the pathogenesis of oral cancer. We characterised the expression and function of IGF-1, IGF-2 and IGF receptor in human oral squamous carcinoma cell lines and normal oral epithelial cells as well as normal oral and squamous cell carcinoma tissues. Using reverse transcription followed by PCR, IGF-1 mRNA was only detected in normal cells, whereas IGF-2 and IGF-1R mRNA transcripts were highly expressed in tumour cell lines and tissues. Similar observations were seen by Western blot analysis and immunohistochemistry. Exogenous IGF-2, but not IGF-1, caused significant increases in DNA synthesis in the cell lines. IGF-2 also increased cell proliferation which was significantly attenuated in the presence of an IGF-2 neutralizing antibody or one which blocked IGF-1R. Taken together, these studies suggest that autocrine production of IGF-2, together with over-expression of IGF-1R, may be important components controlling the proliferation of oral carcinoma cells.
22
The Insulin-Like Growth Factor-Binding Protein (IGFBP) Superfamily
Vivian Hwa · Endocrine Reviews · 1999 · 463 citations
Insulin-like Growth Factor Expression in Human Cancer Cell Lines
Kathryn Quinn, Anthony M. Treston, Edward J. Unsworth et al. · Journal of Biological Chemistry · 1996 · 181 citations · Full text
Insulin‐Like Growth Factors and Neoplasia
Michaël Pollak · Novartis Foundation symposium · 2004 · 128 citations
Medicine, Endocrinology, Oncology +17